Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Long-term treatment with pacri...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

Bibliographic Details
Main Authors: Harrison, C, Yacoub, A, Scott, B, Mead, A, Gerds, AT, Kiladjian, J-J, Mesa, R, Egyed, M, Scheid, C, Gutierrez, VG, O'Sullivan, J, Buckley, S, Kanellopoulos, K, Mascarenhas, J
Format: Journal article
Language:English
Published: Ferrata Storti Foundation 2023
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis
    by: Claire Harrison, et al.
    Published: (2023-01-01)
  • P1069: RETROSPECTIVE COMPARISON OF PATIENT OUTCOMES ON PACRITINIB VERSUS RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND THROMBOCYTOPENIA
    by: C. Harrison, et al.
    Published: (2022-06-01)
  • Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis
    by: Gerds, AT, et al.
    Published: (2020)
  • Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
    by: Srdan Verstovsek, et al.
    Published: (2021-09-01)
  • <i>Erratum</i> to: Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
    by: Srdan Verstovsek, et al.
    Published: (2024-04-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs